نتائج البحث - "Paul Lorigan"

1

Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer

المساهمون: Pulmonary Medicine

المصدر: Journal of Clinical Oncology, 34(31), 3740-+. American Society of Clinical Oncology
Europe PubMed Central

مصطلحات موضوعية: 0301 basic medicine, Adult, Diarrhea, Male, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Neutropenia, medicine.medical_treatment, Ipilimumab, Kaplan-Meier Estimate, Placebo, Gastroenterology, Carboplatin, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, SDG 3 - Good Health and Well-being, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Lung cancer, Etoposide, Aged, Neoplasm Staging, Aged, 80 and over, Chemotherapy, business.industry, Hazard ratio, Middle Aged, medicine.disease, Small Cell Lung Carcinoma, Surgery, 030104 developmental biology, Treatment Outcome, Oncology, chemistry, 030220 oncology & carcinogenesis, Female, Cisplatin, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33422fcfad4240e726a78a0df7ba7ec9Test
https://pure.eur.nl/en/publications/116017bb-e1ce-4d1a-a62f-33b501e3e0a1Test

2

Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin

المؤلفون: Astra M. Liepa, Patrick Peterson, Martin Reck, Mark A. Socinski, Egbert F. Smit, Nick Thatcher, Susan C. Guba, Paul Lorigan, Ewa Szutowicz-Zielińska, Katherine B. Winfree

المساهمون: Pulmonary medicine, CCA - Quality of life

المصدر: Reck, M, Thatcher, N, Smit, E F, Lorigan, P, Szutowicz-Zielinska, E, Liepa, A M, Winfree, K B, Peterson, P, Guba, S C & Socinski, MA 2012, ' Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin ', Lung Cancer, vol. 78, no. 3, pp. 276-281 . https://doi.org/10.1016/j.lungcan.2012.09.002Test
Lung Cancer, 78(3), 276-281. Elsevier Ireland Ltd

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Guanine, Lung Neoplasms, Kaplan-Meier Estimate, Pemetrexed, Severity of Illness Index, Disease-Free Survival, Carboplatin, chemistry.chemical_compound, Glutamates, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Multicenter Studies as Topic, Extensive stage, neoplasms, Etoposide, Aged, Neoplasm Staging, Proportional Hazards Models, Randomized Controlled Trials as Topic, Retrospective Studies, Aged, 80 and over, Performance status, Proportional hazards model, business.industry, Hazard ratio, Retrospective cohort study, Middle Aged, Prognosis, Small Cell Lung Carcinoma, Surgery, chemistry, Clinical Trials, Phase III as Topic, Quality of Life, Female, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9505cafea27a93757644da01b0f4aea0Test
https://doi.org/10.1016/j.lungcan.2012.09.002Test

3

Randomised phase II study of amrubicin as single agent or in combination with cisplatin versus cisplatin etoposide as first-line treatment in patients with extensive stage small cell lung cancer - EORTC 08062

المؤلفون: Krzystof Konopa, Sabine Margerit, Jan P. van Meerbeeck, Frederique Bustin, Lionel Bosquée, Paul Baas, Ernest Marshall, Baktiar Hasan, Christian Fink, Anne-Marie C. Dingemans, Paul Lorigan, Mary O'Brien, Jos A. Stigt

المساهمون: Pulmonologie, RS: GROW - School for Oncology and Reproduction

المصدر: European Journal of Cancer, 47(15), 2322-2330. ELSEVIER SCI LTD

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30ca0869b62744c52621889e5634771dTest
https://cris.maastrichtuniversity.nl/en/publications/c1107e40-ee75-48a1-9458-3d3eae043791Test

4

Outcomes of small-cell lung cancer patients treated with second-line chemotherapy: A multi-institutional retrospective analysis

المصدر: Lung Cancer. 72:378-383

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c5f2c04e762a77395f03c273d50f6abTest
https://doi.org/10.1016/j.lungcan.2010.09.009Test

5

Phase III randomised trial of doxorubicin-based chemotherapy compared with platinum-based chemotherapy in small-cell lung cancer

المؤلفون: Corinne Faivre-Finn, Nick Thatcher, Fiona H Blackhall, Raffaele Califano, L. Aschroft, Sofia Baka, Roberta Ferraldeschi, Paul Lorigan, Paul D. Taylor

المصدر: British Journal of Cancer

مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Anthracycline, Cyclophosphamide, medicine.medical_treatment, cisplatin, Neutropenia, chemotherapy, doxorubicin, Gastroenterology, randomised clinical trial, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, Clinical Studies, Antineoplastic Combined Chemotherapy Protocols, small-cell lung cancer, medicine, Humans, Extensive stage, Carcinoma, Small Cell, Lung cancer, Etoposide, Aged, Monitoring, Physiologic, 030304 developmental biology, Aged, 80 and over, 0303 health sciences, Chemotherapy, business.industry, Middle Aged, medicine.disease, Survival Analysis, Carboplatin, 3. Good health, Surgery, Oncology, chemistry, 030220 oncology & carcinogenesis, Female, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bc28750c58157ca97e675a971120b98Test
https://doi.org/10.1038/sj.bjc.6604480Test

6

Phase 1/2 Study of the CD56-Targeting Antibody-Drug Conjugate Lorvotuzumab Mertansine (IMGN901) in Combination With Carboplatin/Etoposide in Small-Cell Lung Cancer Patients With Extensive-Stage Disease

المؤلفون: Dale L. Nepert, David R. Spigel, Margarita Majem, Fred J. Kudrik, Santiago Ponce, Mark A. Socinski, Peter M. Ellis, Paul Lorigan, Jesus Corral, Frederic J. Kaye, Leena Gandhi, Martin Gutierrez, Luis Gonzaga Paz Ares

المساهمون: ImmunoGen Inc

المصدر: Clinical Lung Cancer
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Repisalud
Instituto de Salud Carlos III (ISCIII)
Socinski, M A, Kaye, F J, Spigel, D R, Kudrik, F J, Ponce, S, Ellis, P M, Majem, M, Lorigan, P, Gandhi, L, Gutierrez, M E, Nepert, D, Corral, J & Paz-Ares, L 2017, ' Phase 1/2 Study of the CD56-Targeting Antibody-Drug Conjugate Lorvotuzumab Mertansine (IMGN901) in Combination With Carboplatin/Etoposide in Small-Cell Lung Cancer Patients With Extensive-Stage Disease. ', Clinical Lung Cancer, vol. 18, no. 1, PMID: 2834110, pp. 68-76 . https://doi.org/10.1016/j.cllc.2016.09.002Test

مصطلحات موضوعية: Male, 0301 basic medicine, Cancer Research, Immunoconjugates, Lung Neoplasms, Pharmacology, Carboplatin, Lorvotuzumab mertansine, chemistry.chemical_compound, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Molecular Targeted Therapy, Etoposide, Aged, 80 and over, Targeted drug delivery, Manchester Cancer Research Centre, SCLC, Antibodies, Monoclonal, Middle Aged, Tolerability, Prognosis, CD56 Antigen, Clinical trial, Survival Rate, Oncology, 030220 oncology & carcinogenesis, Female, medicine.drug, Adult, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Combination therapy, Urology, 03 medical and health sciences, medicine, Humans, Maytansine, Extensive stage, Lung cancer, Adverse effect, Aged, Neoplasm Staging, business.industry, ResearchInstitutes_Networks_Beacons/mcrc, medicine.disease, Small Cell Lung Carcinoma, 030104 developmental biology, chemistry, business, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac929c5bd80dd3465fd3229718f3bad6Test
https://doi.org/10.1016/j.cllc.2016.09.002Test

7

True

المؤلفون: Robert E. Coleman, Barry W. Hancock, Paul Lorigan, L S Dobson

المصدر: British Journal of Cancer. 82:1547-1552

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::a2d47920a23faa3f720950b378cbc0eaTest
https://doi.org/10.1054/bjoc.2000.1176Test

8

Biomarker analysis in a phase III study of pemetrexed-carboplatin versus etoposide-carboplatin in chemonaive patients with extensive-stage small-cell lung cancer

المؤلفون: Ma Socinski, Sp Myrand, J. von Pawel, Aleksandra Szczesna, Giorgio V. Scagliotti, Bp Mullaney, Nick Thatcher, Sc Guba, Na Karaseva, Martin Reck, Rr Hozak, E. Powell, Ef Smit, Tudor-Eliade Ciuleanu, Paul Lorigan, S Hong, D Ohannesian

المساهمون: Pulmonary medicine, CCA - Innovative therapy

المصدر: Smit, E F, Socinski, M, Mullaney, B, Myrand, S, Scagliotti, G V, Lorigan, P, Reck, M, Ciuleanu, T, van Pawel, J, Karaseva, N, Szczesna, A, Ohannesian, D, Powell, E, Hozak, R, Hong, S, Guba, S & Thatcher, N 2012, ' Biomarker analysis in a phase III study of pemetrexed-carboplatin versus etoposide-carboplatin in chemonaive patients with extensive-stage small-cell lung cancer ', Annals of Oncology, vol. 23, no. 7, pp. 1723-1729 . https://doi.org/10.1093/annonc/mdr563Test
Annals of Oncology, 23(7), 1723-1729. Oxford University Press

مصطلحات موضوعية: Guanine, Lung Neoplasms, Kaplan-Meier Estimate, Pemetrexed, Polymorphism, Single Nucleotide, Thymidylate synthase, Disease-Free Survival, Carboplatin, Reduced Folate Carrier Protein, chemistry.chemical_compound, Glutamates, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, medicine, Humans, Peptide Synthases, Lung cancer, Methylenetetrahydrofolate Reductase (NADPH2), Etoposide, Phosphoribosylglycinamide Formyltransferase, Randomized Controlled Trials as Topic, biology, business.industry, Folylpolyglutamate synthase, Thymidylate Synthase, Hematology, Endonucleases, medicine.disease, Small Cell Lung Carcinoma, Collagen Type XVIII, DNA-Binding Proteins, Logistic Models, Clinical Trials, Phase III as Topic, Oncology, chemistry, Folate receptor, Methylenetetrahydrofolate reductase, Cancer research, biology.protein, ERCC1, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::876335ea495a4ca1a70a62600c4c29feTest
https://research.vumc.nl/en/publications/3cd0fa52-338d-40ee-85c6-45a87fd3b3ccTest

9

Omitting elective nodal irradiation during thoracic irradiation in limited-stage small cell lung cancer--evidence from a phase II trial

المؤلفون: Nick Thatcher, Fiona H Blackhall, Hamid Y Sheikh, Paul Hulse, Raffaele Califano, Rovel J. Colaco, Linda Ashcroft, Paul Lorigan, Paul Taylor, Corinne Faivre-Finn

المصدر: Lung cancer (Amsterdam, Netherlands). 76(1)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0574c80500ae8403d18d7a88d3233e5Test
https://pubmed.ncbi.nlm.nih.gov/22014897Test

10

Phase III study of pemetrexed plus carboplatin compared with etoposide plus carboplatin in chemotherapy-naive patients with extensive-stage small-cell lung cancer

المؤلفون: Martin Reck, Tudor Ciuleanu, Coleman K. Obasaju, Nina Karaseva, Susan C. Guba, Shengyan Hong, Egbert F. Smit, Nick Thatcher, Kartik Konduri, Johnetta Blakely, Carla Visseren-Grul, Aleksandra Szczesna, Jacek Jassem, Paul Lorigan, Mircea Dediu, Axel Hanauske, Piotr Serwatowski, Mark A. Socinski

المساهمون: Pulmonary medicine, CCA - Innovative therapy

المصدر: Socinski, MA, Smit, E F, Lorigan, P, Konduri, K, Reck, M, Szczesna, A, Blakely, J, Serwatowski, P, Karaseva, N A, Ciuleanu, T, Jassem, J, Dediu, M, Hong, SH, Visseren-Grul, C, Hanauske, A R, Obasaju, C K, Guba, S C & Thatcher, N 2009, ' Phase III Study of Pemetrexed Plus Carboplatin Compared With Etoposide Plus Carboplatin in Chemotherapy-Naive Patients With Extensive-Stage Small-Cell Lung Cancer ', Journal of Clinical Oncology, vol. 27, no. 28, pp. 4787-4792 . https://doi.org/10.1200/JCO.2009.23.1548Test
Journal of Clinical Oncology, 27(28), 4787-4792. American Society of Clinical Oncology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f04e39a599f28bc6151b6c45b0f29420Test
https://pubmed.ncbi.nlm.nih.gov/19720897Test

تنقيح النتائج